Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jul 24, 2024
Document Date
Jul 22, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
DULAC EDWARD J III